The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ACADIA PHARMACEUTICALS INC COM 004225108 24,074 450,317 SH   SOLE N/A 450,317 0 0
ALLAKOS INC COM 01671P100 20,673 147,662 SH   SOLE N/A 147,662 0 0
AMARIN CORP PLC SPONS ADR NEW 023111206 7,375 1,508,237 SH   SOLE N/A 1,508,237 0 0
AMICUS THERAPEUTICS INC COM 03152W109 30,372 1,315,395 SH   SOLE N/A 1,315,395 0 0
ARGENX SE SPONSORED ADR 04016X101 14,690 49,950 SH   SOLE N/A 49,950 0 0
AXSOME THERAPEUTICS INC COM 05464T104 17,931 220,098 SH   SOLE N/A 220,098 0 0
COGENT BIOSCIENCES INC COM 19240Q201 17,507 1,558,975 SH   SOLE N/A 1,558,975 0 0
ENANTA PHARMACEUTICALS INC COM 29251M106 6,333 150,433 SH   SOLE N/A 150,433 0 0
GLOBAL BLOOD THERAPEUTICS IN COM 37890U108 9,312 215,000 SH   SOLE N/A 215,000 0 0
INSMED INC COM PAR $.01 457669307 32,018 961,797 SH   SOLE N/A 961,797 0 0
IOVANCE BIOTHERAPEUTICS INC COM 462260100 26,257 565,890 SH   SOLE N/A 565,890 0 0
KARYOPHARM THERAPEUTICS INC COM 48576U106 10,872 702,351 SH   SOLE N/A 702,351 0 0
MIRAGEN THERAPEUTICS INC COM NEW 60463E202 554 35,092 SH   SOLE N/A 35,092 0 0
MIRATI THERAPEUTICS INC COM 60468T105 13,288 60,500 SH   SOLE N/A 60,500 0 0
SERES THERAPEUTICS INC COM 81750R102 6,297 257,016 SH   SOLE N/A 257,016 0 0
TRILLIUM THERAPEUTICS INC COM NEW 89620X506 21,744 1,478,181 SH   SOLE N/A 1,478,181 0 0
VERONA PHARMA PLC SPONSORED ADS 925050106 700 100,000 SH   SOLE N/A 100,000 0 0
ZOGENIX INC COM NEW 98978L204 19,603 980,645 SH   SOLE N/A 980,645 0 0